GSK to acquire Sierra Oncology for US $1.9bn
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Parkinson’s is not limited to old people, even youngsters can suffer from this disease
The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Subscribe To Our Newsletter & Stay Updated